BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $26,823,000 | -17.2% | 417,608 | 0.0% | 2.90% | -1.4% |
| Q1 2022 | $32,381,000 | +30.1% | 417,608 | +45.2% | 2.94% | -4.8% |
| Q4 2021 | $24,880,000 | +19.4% | 287,608 | +11.0% | 3.09% | +5.2% |
| Q3 2021 | $20,833,000 | -0.1% | 259,020 | 0.0% | 2.94% | -2.8% |
| Q2 2021 | $20,851,000 | -4.6% | 259,020 | 0.0% | 3.02% | -12.7% |
| Q1 2021 | $21,846,000 | +13.2% | 259,020 | +26.6% | 3.47% | +22.9% |
| Q4 2020 | $19,304,000 | +22.4% | 204,535 | +4.3% | 2.82% | -10.8% |
| Q3 2020 | $15,773,000 | -6.6% | 196,133 | 0.0% | 3.16% | -14.4% |
| Q2 2020 | $16,887,000 | +5.9% | 196,133 | 0.0% | 3.69% | -11.7% |
| Q1 2020 | $15,951,000 | +20.0% | 196,133 | +23.3% | 4.18% | +39.0% |
| Q4 2019 | $13,288,000 | +1.8% | 159,029 | +6.6% | 3.01% | -7.4% |
| Q3 2019 | $13,053,000 | +6.8% | 149,201 | 0.0% | 3.25% | +13.9% |
| Q2 2019 | $12,218,000 | +3.3% | 149,201 | +1.9% | 2.85% | -2.0% |
| Q1 2019 | $11,828,000 | -7.2% | 146,382 | 0.0% | 2.91% | +4.6% |
| Q4 2018 | $12,752,000 | -12.3% | 146,382 | 0.0% | 2.78% | -5.1% |
| Q3 2018 | $14,537,000 | +1251.0% | 146,382 | +904.5% | 2.94% | +699.7% |
| Q2 2018 | $1,076,000 | -33.7% | 14,573 | -50.0% | 0.37% | -27.0% |
| Q1 2018 | $1,624,000 | – | 29,146 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |